- Metabolic Dysfunction After Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer
- Hindsight Bias in Diagnosis
- Systemic Therapy Considerations in Older Adults With Early-Stage Breast Cancer
- JAMA Oncology
- Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability
- Supplements and Wellness Products During Cancer Care
- Cancer Biologics Utilization After Biosimilar Entry and Financial Implications For Payers and Patients
- Adult T-Cell Leukemia/Lymphoma and Maternal Screening—Reply
- Oral Ulcers in a Patient With Myelodysplastic Syndrome
- Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability
- Managing Metabolic Syndrome and Prostate Cancer
- Recent FDA Decisions and the Future of the Development of Cancer Drugs in the US
- Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability—Reply
- Learning Leadership by Quality Improvement
- Tissue-Free vs Tumor-Informed Circulating Tumor DNA Assays in Early Triple Negative Breast Cancer
